Palmer Deborah, El Miedany Yasser
Advanced Nurse Practitioner, North Middlesex University Hospital, London.
Consultant Rheumatologist, Darent Valley Hospital, Dartford.
Br J Nurs. 2014;23(6):310-5. doi: 10.12968/bjon.2014.23.6.310.
Integrating the rheumatoid arthritis (RA) treat-to-target concept into standard clinical practice represents a challenge to health professionals. So far, this practice-changing approach has not been widely implemented, in spite of linking its outcome to payment, which was adopted in the best practice tariffs. The recently published revisions in classification criteria and updated recommendations for optimising the use of disease-modifying anti-rheumatic and biologic agents in the treatment of RA paved the way for re-evaluating the standard clinical care models in order to improve patient outcomes, prevent joint damage, and maintain patients' functional ability as well as their quality of life. This article discusses the recent advances in the management of RA and provides a set of recommendations to provide comprehensive guidance for treatment to target with the aim of improving the quality of care for RA patients.
将类风湿关节炎（RA）治疗达标理念融入标准临床实践对医疗专业人员而言是一项挑战。尽管将其治疗结果与支付挂钩（这已被纳入最佳实践收费标准），但到目前为止，这种改变实践的方法尚未得到广泛实施。最近发布的分类标准修订版以及关于优化改善病情抗风湿药和生物制剂在RA治疗中使用的更新建议，为重新评估标准临床护理模式铺平了道路，以便改善患者预后、预防关节损伤，并维持患者的功能能力及其生活质量。本文讨论了RA管理方面的最新进展，并提供了一系列建议，为达标治疗提供全面指导，旨在提高RA患者的护理质量。
